175402-01-4

Basic information

• Product Name: (S)-3-{[2-(4-Cyano-phenyl)-1H-benzoimidazole-5-carbonyl]-amino}-N-[2-(1H-indol-3-yl)-ethyl]-succinamic acid methyl ester
• CAS NO: 175402-01-4
• Molecular Weight: 534.574
• Mol File: 175402-01-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-3-{[2-(4-Cyano-phenyl)-1H-benzoimidazole-5-carbonyl]-amino}-N-[2-(1H-indol-3-yl)-ethyl]-succinamic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-{[2-(4-Cyano-phenyl)-1H-benzoimidazole-5-carbonyl]-amino}-N-[2-(1H-indol-3-yl)-ethyl]-succinamic acid methyl ester(175402-01-4)
• EPA Substance Registry System: (S)-3-{[2-(4-Cyano-phenyl)-1H-benzoimidazole-5-carbonyl]-amino}-N-[2-(1H-indol-3-yl)-ethyl]-succinamic acid methyl ester(175402-01-4)

Safety Data

• Hazardous Substances Data: 175402-01-4(Hazardous Substances Data)

Upstream product

• 619-05-6 3,4-diaminobenzoic acid 
• 105-07-7 4-cyanobenzaldehyde 
• 6068-72-0 4-cyanobenzoyl chlorIde 
• 175401-95-3 2-(4-cyanophenyl)benzimidazole-5-carboxylic acid 

Downstream Products

• 175402-11-6 (S)-3-{[2-(4-Aminomethyl-phenyl)-1H-benzoimidazole-5-carbonyl]-amino}-N-[2-(1H-indol-3-yl)-ethyl]-succinamic acid methyl ester 

Relevant articles and documents

Design, synthesis and in vitro activities of a series benzimidazole/benzoxazole glycoprotein IIb/IIIa inhibitors

A potent centrally constrained series of benzimidazole and benzoxazole glycoprotein IIb/IIIa inhibitors has been discovered based on the solution conformation of a cyclic RGD-containing peptide, DMP 728. The high potency of this series of compounds in the inhibition of platelet aggregation requires a benzamidine as the basic moiety and an α-carbamate or sulfonamide substituted β-alanine as the acidic moiety.